← back to search

Qiaoxuan Zhang

Guangzhou University of Chinese Medicine · CN
Area of research
Endocrinology, Diabetes and Metabolism · Biomedical Engineering
Research interest
Research interests include Chromatography, Chemistry, Isotope dilution, Medicine, Computational biology, and Mass spectrometry.
h-index
citations
461
works
59
NIH funding
primary concept
email

Recent publications

Income, diet, and cognitive function: observational analyses and candidate metabolomic pathways identified by Mendelian randomization
The Journal of Prevention of Alzheimer s Disease 2026cited by 0position: middledoi
Anti‐CRISPR Protein Regulates CRISPR/Cas12a Fusogenic‐Nanovesicle‐Based Platform for Extracellular Vesicle‐Encapsulated Non‐Nucleic Acid Target In‐Vesicle Detection
Angewandte Chemie International Edition 2026cited by 0position: firstdoi
Anti‐CRISPR Protein Regulates CRISPR/Cas12a Fusogenic‐Nanovesicle‐Based Platform for Extracellular Vesicle‐Encapsulated Non‐Nucleic Acid Target In‐Vesicle Detection
Angewandte Chemie 2026cited by 0position: firstdoi
Design, synthesis, and biological evaluation of Osimertinib–Cy7 (OSA-Cy7) conjugate as potential theranostic agent targeting activating EGFR mutations
BMC Biotechnology 2025cited by 1position: middledoi
Deciphering the mechanism and substance basis of Dingxiang Shidi Decoction for the treatment of chemotherapy-induced nausea and vomiting by integrating mass spectrometry, network pharmacology and molecular docking
Technology and Health Care 2025cited by 0position: middledoi
Hedgehog-nanovesicles redox probe based “explosive” signal amplification biosensing platform for Alzheimer's disease early diagnosis
Chemical Engineering Journal 2025cited by 0position: lastdoi
Novel dimer dsDNA capture probe coupled with 4-MPBA@AuNPs@6-(Fc)HT ratiometric electrochemical biosensor for the detection of high-affinity anti-dsDNA antibodies
Biosensors and Bioelectronics 2025cited by 0position: lastdoi
Copper metabolism-related biomarkers and therapeutic targets for diabetic nephropathy
PeerJ 2025cited by 0position: middledoi
Development and validation of a candidate reference measurement procedure for free triiodothyronine and free thyroxine in human serum using equilibrium dialysis isotope-dilution liquid chromatography-tandem mass spectrometry
Clinical Chemistry and Laboratory Medicine (CCLM) 2025cited by 0position: middledoi
Comparative evaluation of immunoaffinity and antibody-free isotope dilution mass spectrometry approaches for plasma ProGRP quantification
Analytical and Bioanalytical Chemistry 2025cited by 0position: middledoi
Zwitterionic sulfobetaine-based hypercrosslinked hydrophilic materials for bioanalysis
Chemical Engineering Journal 2024cited by 11position: firstdoi
Identification of mitochondria-related genes as diagnostic biomarkers for diabetic nephropathy and their correlation with immune infiltration: New insights from bioinformatics analysis
International Immunopharmacology 2024cited by 9position: middledoi
Development of simultaneous quantitation method for 20 free advanced glycation end products using UPLC–MS/MS and clinical application in kidney injury
Journal of Pharmaceutical and Biomedical Analysis 2024cited by 4position: middledoi
Evaluation and clinical application of a bracketing calibration-based isotope dilution liquid chromatography-tandem mass spectrometry candidate reference measurement procedure for serum theophylline
Analytical and Bioanalytical Chemistry 2024cited by 4position: middledoi
Electroactive supramolecular nanoprobes for electrochemical detection of rituximab in non-Hodgkon’s lymphoma patients
Chemical Engineering Journal 2024cited by 4position: middledoi
Establishment and clinical application of a candidate reference measurement procedure for quantification of urinary vanillylmandelic acid and homovanillic acid using ID-LC-MS/MS method
Journal of Pharmaceutical and Biomedical Analysis 2024cited by 3position: middledoi
An optimized UPLC-MS/MS method for human plasma amyloid-β 42 and 40 measurement and application in Alzheimer's disease diagnosis
Journal of Pharmaceutical and Biomedical Analysis 2024cited by 3position: firstdoi
Evaluation for serum glucose standardization in clinical laboratories of Southern China by consecutive 6 years proficiency testing based on JCTLM-recommended reference methods
Journal of Laboratory Medicine 2024cited by 1position: middledoi
Establishment and Clinical Application of a Candidate Reference Measurement Procedure for Quantification of Urinary Vanilmandelic Acid and Homovanillic Acid Using Id-Lc-Ms/Ms Method
SSRN Electronic Journal 2024cited by 0position: middledoi
A novel herbal aromatic essential oil for treating Chemotherapy-Induced Nausea and Vomiting: a mass spectrometry and network pharmacology study of the traditional Chinese medicine formula
Research Square 2024cited by 0position: middledoi
A DNA-peptide probe coupled mass spectrometry-based method for the detection of LncRNA in hepatocyte and serum samples
Microchemical Journal 2024cited by 0position: lastdoi
Potential drug targets for prostate cancer : A mendelian randomization study and application for target-derived drug design
Research Square 2024cited by 0position: middledoi
Absolute quantitation of human serum cystatin C: candidate reference method by <sup>15</sup> N-labeled recombinant protein isotope dilution UPLC-MS/MS
Clinical Chemistry and Laboratory Medicine (CCLM) 2024cited by 0position: firstdoi
Potential Drug Targets for Prostate Cancer: A Mendelian Randomization Study and Application for Target-Derived Drug Design
SSRN Electronic Journal 2024cited by 0position: middledoi
Clinical application of an optimized reference measurement procedure for serum digoxin using bracketing calibration method by ID-LC-MS/MS
Analytical and Bioanalytical Chemistry 2024cited by 0position: middledoi
Serum 25-hydroxyvitamin D status of a large Chinese population from 30 provinces by LC–MS/MS measurement for consecutive 3 years: differences by age, sex, season and province
European Journal of Nutrition 2023cited by 25position: middledoi
Novel dual-targeting inhibitors of NSD2 and HDAC2 for the treatment of liver cancer: structure-based virtual screening, molecular dynamics simulation, and <i>in vitro</i> and <i>in vivo</i> biological activity evaluations
Journal of Enzyme Inhibition and Medicinal Chemistry 2023cited by 10position: middledoi
Quantitative Detection of 15 Serum Bile Acid Metabolic Products by LC/MS/MS in the Diagnosis of Primary Biliary Cholangitis
Chemistry & Biodiversity 2023cited by 8position: middledoi
Identification of Copper Metabolism Related Biomarkers, Polygenic Prediction Model, and Potential Therapeutic Agents in Alzheimer’s Disease
Journal of Alzheimer s Disease 2023cited by 7position: lastdoi
Tetrapeptide-based mimotope affinity monolith for the enrichment and analysis of anti-HER2 antibody and antibody-drug conjugate
Analytica Chimica Acta 2023cited by 7position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Liqiao Han · Guangzhou University of Chinese Medicine41 papers (2015–2026)Xianzhang Huang · Guangzhou University of Chinese Medicine29 papers (2018–2026)Haibiao Lin · Advanced Materials and Devices (United States)22 papers (2015–2025)Jun Yan · Guangzhou University of Chinese Medicine22 papers (2018–2025)Peifeng Ke · Guangzhou University of Chinese Medicine20 papers (2015–2025)Junhua Zhuang · Guangzhou University of Chinese Medicine17 papers (2015–2024)Min Zhan · Guangzhou University of Chinese Medicine17 papers (2021–2025)Pengwei Zhang · Guangzhou University of Chinese Medicine16 papers (2022–2025)Xianzhang Huang · Guangzhou University of Chinese Medicine12 papers (2015–2025)Qiqin Wang · Guangzhou University of Chinese Medicine10 papers (2018–2026)Jianbing Wang · Guangzhou University of Chinese Medicine8 papers (2018–2024)Jianbing Wang · Guangzhou University of Chinese Medicine7 papers (2015–2025)Zemin Wan · Guangzhou University of Chinese Medicine7 papers (2015–2025)Zhengjin Jiang · Jinan University7 papers (2015–2024)Xianzhang Huang · Guangzhou University of Chinese Medicine6 papers (2022–2024)Zhiliang Cai · Guangzhou University of Chinese Medicine6 papers (2019–2022)Qiaofang Yan · Guangzhou University of Chinese Medicine5 papers (2024–2025)Min Zhan · Guangzhou University of Chinese Medicine5 papers (2023–2025)Min Zhan · University of Illinois Urbana-Champaign5 papers (2023–2024)Shiyue Kang · Guangzhou University of Chinese Medicine5 papers (2024–2024)